CC
SZYM

Callan Capital’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Callan Capital’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-42,250
Closed -$498K – 80
2014
Q2 		$498K Buy
42,250
+17,250
+69% +$184K 0.13% 48
2014
Q1 		$290K Buy
25,000
+4,500
+22% +$52.9K 0.1% 43
2013
Q4 		$223K Buy
20,500
+5,500
+37% +$54.1K 0.09% 41
2013
Q3 		$162K Buy
15,000
+3,000
+25% +$34.2K 0.08% 39
2013
Q2 		$141K Buy
+12,000
New +$120K 0.08% 34

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Callan Capital's SZYM Position: Q3 2014 in Review

Callan Capital sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q3 2014, closing a stake of 42,250 shares — an estimated $498K sold.

Callan Capital first reported a position in SZYM in Q2 2013 and held it in 5 quarters. The position peaked at $498K in Q2 2014. 120 funds tracked by Wall St. Rank hold SZYM as of Q3 2014.

  • Callan Capital reported no remaining SOLAZYME INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Callan Capital sold 42,250 SOLAZYME INC COM STK (DE) shares in Q3 2014, an estimated $498K.
  • Callan Capital first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Callan Capital's SOLAZYME INC COM STK (DE) position peaked at $498K in Q2 2014.
  • 120 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2014.

Based on Callan Capital's 13F filing for Q3 2014, filed 12 Nov 2014.